Description: 
 

Apremilast is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It has anti-inflammatory activity.
Puhopharma specializes in controling the quality and reducing the impurities of Apremilast.
Our Apremilast is with the best quality and the most competitive price in China
[Application scope] for the treatment of psoriatic arthritis and offers the convenience of oral dosing compared to treatment with biopharmaceuticals.It is also being tested for its efficacy in treating other chronic inflammatory diseases such as ankylosing spondylitis, Behcet's disease, and rheumatoid arthritis.